New Issue: Nile Therapeutics seals $3.36 million placement of shares with warrants

By Devika Patel

Knoxville, Tenn., July 13 - Nile Therapeutics, Inc. detailed a $3.36 million private placement of stock in an 8-K filed Monday with the Securities and Exchange Commission. The deal settled July 7.

The company sold 2,691,394 shares at $1.25 per share.

The investors also received warrants for 2,691,394 common shares. Of the five-year warrants, 25% are exercisable at $1.25, 25% are exercisable at $1.71 and 50% are exercisable at $2.28.

San Francisco-based Nile is a biopharmaceutical company.

Issuer:	Nile Therapeutics, Inc.
Issue:	Stock
Amount:	$3,364,242.50
Shares:	2,691,394
Price:	$1.25
Warrants:	For 2,691,394 shares
Warrant expiration:	Five years
Warrant strike price:	$1.25 (for 25%), $1.71 (for 25%), $2.28 (for 50%)
Settlement date:	July 7
Stock symbol:	Nasdaq: NLTX
Stock price:	$1.14 at close July 7
Market capitalization:	$41.8 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.